152 related articles for article (PubMed ID: 10610397)
1. Pergolide monotherapy for Parkinson's disease.
van der Worp B
J Neurol; 1999 Oct; 246(10):983-4. PubMed ID: 10610397
[No Abstract] [Full Text] [Related]
2. DA agonists -- ergot derivatives: pergolide: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S79-82. PubMed ID: 12211145
[No Abstract] [Full Text] [Related]
3. Pergolide and Parkinson's disease: new preparation. No clear benefit.
Prescrire Int; 2000 Dec; 9(50):177-9. PubMed ID: 11475497
[TBL] [Abstract][Full Text] [Related]
4. [Pergolide: a useful agonist for the treatment of Parkinson disease].
Bonnet AM; Houeto JL
Rev Neurol (Paris); 2002 Jul; 158(6-7):744-5. PubMed ID: 12486908
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
Navan P; Findley LJ; Jeffs JA; Pearce RK; Bain PG
Mov Disord; 2003 Feb; 18(2):176-80. PubMed ID: 12539211
[TBL] [Abstract][Full Text] [Related]
6. Trial of subtherapeutic pergolide in de novo Parkinson's disease.
Grosset K; Grosset D; Lees A;
Mov Disord; 2005 Mar; 20(3):363-6. PubMed ID: 15580607
[TBL] [Abstract][Full Text] [Related]
7. Medical hazards of the internet: gambling in Parkinson's disease.
Larner AJ
Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
[No Abstract] [Full Text] [Related]
8. Pergolide in Parkinson's disease: time for a change?
Grosset KA; Grosset DG
Lancet; 2004 Jun; 363(9424):1907-8. PubMed ID: 15183636
[No Abstract] [Full Text] [Related]
9. [Pergolide use and heart valve fibrosis. Yearly control in patients with Parkinson disease who use pergolide].
van Laar T; Berendse H; Bloem BR; Boon AJ; van Hilten JJ; Hovestadt A; de Koning-Tijssen MA; Nijssen PC; Weber WE
Ned Tijdschr Geneeskd; 2009 Jan; 153(3):87-90. PubMed ID: 19235345
[No Abstract] [Full Text] [Related]
10. Retroperitoneal fibrosis in a patient with Parkinson's disease treated with pergolide.
Jiménez-Jiménez FJ; López-Alvarez J; Sánchez-Chapado M; Montero E; Miquel J; Sierra A; Gutiérrez F
Clin Neuropharmacol; 1995 Jun; 18(3):277-9. PubMed ID: 8635187
[TBL] [Abstract][Full Text] [Related]
11. Burden of cardiovascular diseases in elderly with Parkinson's disease who start a dopamine agonist agent.
Trifirò G; Morgante L; Tari M; Arcoraci V; Savica R
J Am Geriatr Soc; 2008 Feb; 56(2):371-3. PubMed ID: 18251828
[No Abstract] [Full Text] [Related]
12. [Sleep attacks and pergolide mesylate].
García Ruiz PJ; Hernández J; Cantarero S; Fanjul S
Neurologia; 2001 Feb; 16(2):92. PubMed ID: 11257938
[No Abstract] [Full Text] [Related]
13. Pergolide mesylate in Parkinson's disease treatment.
Pezzoli G; Canesi M; Pesenti A; Mariani CB
J Neural Transm Suppl; 1995; 45():203-12. PubMed ID: 8748627
[TBL] [Abstract][Full Text] [Related]
14. [Multiple latency test in a patient with episodes of sleep induced by pergolide].
Jiménez-Jiménez FJ; Velasco I; de Toledo M; Sayed Y; Zurdo J; Ortí-Pareja M
Rev Neurol; 2002 Jun 16-30; 34(12):1140-1. PubMed ID: 12134281
[TBL] [Abstract][Full Text] [Related]
15. Pramipexole for Parkinson's disease.
Ting RM; Force RW
J Fam Pract; 1998 Jan; 46(1):19-20. PubMed ID: 9451363
[No Abstract] [Full Text] [Related]
16. Pergolide-induced lung disease in patients with Parkinson's disease.
Kastelik JA; Aziz I; Greenstone MA; Thompson R; Morice AH
Respir Med; 2002 Jul; 96(7):548-50. PubMed ID: 12194642
[No Abstract] [Full Text] [Related]
17. Valvular heart disease in patients with Parkinson's disease treated with pergolide, levodopa or both.
Ozer F; Tiras R; Cetin S; Ozturk O; Aydemir T; Ozben S; Meral H; Kizkin S; Bader H; Ozben B
J Clin Neurosci; 2009 Jan; 16(1):83-7. PubMed ID: 19014887
[TBL] [Abstract][Full Text] [Related]
18. Treatment of restless leg syndrome with pergolide.
Gunning K; Gay C
J Fam Pract; 1999 Apr; 48(4):250. PubMed ID: 10229243
[No Abstract] [Full Text] [Related]
19. Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy.
Comella CL; Morrissey M; Janko K
Neurology; 2005 Apr; 64(8):1450-1. PubMed ID: 15851743
[TBL] [Abstract][Full Text] [Related]
20. [Impulse control disorder induced by the use of dopamine agonists].
Weber WE; Nijssen PC
Ned Tijdschr Geneeskd; 2009 Jan; 153(3):80-1. PubMed ID: 19235343
[No Abstract] [Full Text] [Related]
[Next] [New Search]
